In Israel, a third dose of Pfizer’s COVID-19-19 vaccine has significantly improved infection protection and serious illness among people aged 60 and older in Israel compared with those who received two shots,
findings published by the Health Ministry showed on Sunday.
The third jab for over 60-year-olds offered five to six times greater protection after 10 days with regard to serious illness and hospitalization.
That age group is particularly vulnerable to COVD and in Israel was the first to be inoculated when the vaccine drive began in late December.
The findings were on par with separate statistics reported last week by Israel’s Maccabi healthcare provider, one of several organizations administering booster shots to try to curb the Delta coronavirus variant.